King Wealth Management Group’s Boston Scientific BSX Stock Holding History

King Wealth Management Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Buy	36,514 +29,514	+422%	+$1.6M	0.17%	58
2026 Q1	$439K	Buy	+7,000	New	+$560K	0.05%	111
2022 Q1	–	Sell	-20,060	Closed	-$852K	–	174
2021 Q4	$852K	Sell	20,060 -9,000	-31%	-$378K	0.16%	70
2021 Q3	$1.26M	Hold	29,060	–	–	0.26%	52
2021 Q2	$1.24M	Hold	29,060	–	–	0.25%	56
2021 Q1	$1.12M	Sell	29,060 -8,000	-22%	-$303K	0.25%	62
2020 Q4	$1.33M	Buy	37,060 +17,000	+85%	+$613K	0.31%	52
2020 Q3	$766K	Buy	20,060 +60	+0.3%	+$2.31K	0.2%	69
2020 Q2	$702K	Buy	20,000 +1,000	+5%	+$36K	0.21%	67
2020 Q1	$620K	Buy	+19,000	New	+$742K	0.27%	57

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

King Wealth Management Group's BSX Position: Q2 2026 in Review

King Wealth Management Group increased its Boston Scientific (BSX) stake by 422% in Q2 2026, buying an estimated $1.6M and bringing the position to 36,514 shares worth $1.56M. The position accounts for 0.17% of the portfolio, ranked #58.

King Wealth Management Group first reported a position in BSX in Q1 2020 and has held it in 10 quarters since. 1,481 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

King Wealth Management Group held 36,514 shares of Boston Scientific worth $1.56M as of Q2 2026.
King Wealth Management Group bought 29,514 Boston Scientific shares in Q2 2026, an estimated $1.6M.
Boston Scientific made up 0.17% of King Wealth Management Group's portfolio in Q2 2026, its #58 holding.
King Wealth Management Group first reported a position in Boston Scientific in Q1 2020 and has held it in 10 quarters since.
1,481 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on King Wealth Management Group's 13F filing for Q2 2026, filed 5 Aug 2026.